Zacks Small Cap Analysis – TNXP: No AdCom Required for TNX-102 SL NDA… – Digital Digest
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Enterprise Replace No Advisory Committee Assembly for TNX-102 SL NDA On March 24, 2025, Tonix Prescribed drugs Corp. (NASDAQ:TNXP) introduced that the FDA is not going to require an Advisory Committee (AdCom) assembly relating to the New Drug Utility (NDA) for TNX-102 SL for … Read more